This company listing is no longer active
Resumen de acción BNOE.F
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Competidores de Bionomics Limited
Historial de precios y rendimiento
Historical stock prices | |
---|---|
Current Share Price | US$0.006 |
52 Week High | US$0.055 |
52 Week Low | US$0.0013 |
Beta | 1.84 |
1 Month Change | -39.39% |
3 Month Change | -72.73% |
1 Year Change | -80.20% |
3 Year Change | -95.00% |
5 Year Change | -98.46% |
Change since IPO | -98.13% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
BNOE.F | US Biotechs | Mercado US | |
---|---|---|---|
7D | -25.0% | 0.5% | 2.7% |
1Y | -80.2% | 3.4% | 26.0% |
Rentabilidad vs. Industria: BNOE.F underperformed the US Biotechs industry which returned 7.8% over the past year.
Rentabilidad vs. Mercado: BNOE.F underperformed the US Market which returned 11.8% over the past year.
Volatilidad de los precios
BNOE.F volatility | |
---|---|
BNOE.F Average Weekly Movement | 216.2% |
Biotechs Industry Average Movement | 11.3% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: BNOE.F's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: BNOE.F's weekly volatility has increased from 137% to 216% over the past year.
Acerca de la empresa
Fundada | Empleados | CEO | Página web |
---|---|---|---|
1996 | n/a | Spyros Papapetropoulos | www.bionomics.com.au |
Resumen de fundamentos de Bionomics Limited
Estadísticas fundamentales de BNOE.F | |
---|---|
Capitalización bursátil | US$8.81m |
Beneficios(TTM) | -US$16.08m |
Ingresos (TTM) | US$3.89m |
2.3x
Ratio precio-ventas (PS)-0.5x
Ratio precio-beneficio (PE)¿Está BNOE.F sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
Cuenta de resultados (TTM) de BNOE.F | |
---|---|
Ingresos | AU$6.02m |
Coste de los ingresos | AU$19.80m |
Beneficio bruto | -AU$13.79m |
Otros gastos | AU$11.13m |
Beneficios | -AU$24.91m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) | -0.017 |
Margen bruto | -229.04% |
Margen de beneficio neto | -413.94% |
Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado BNOE.F a largo plazo?
Ver rendimiento histórico y comparativa